agilon health (NYSE:AGL) Trading Down 7.6%

agilon health, inc. (NYSE:AGL)’s share price fell 7.6% on Tuesday . The company traded as low as $3.60 and last traded at $3.63. 2,507,541 shares traded hands during trading, a decline of 50% from the average session volume of 4,967,347 shares. The stock had previously closed at $3.93.

Analyst Ratings Changes

AGL has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft decreased their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Benchmark reiterated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Royal Bank of Canada restated an “outperform” rating and set a $8.00 target price on shares of agilon health in a research note on Wednesday, August 7th. Finally, Evercore ISI increased their price target on shares of agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a research note on Tuesday, July 9th. One investment analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $8.57.

agilon health Stock Performance

The stock has a fifty day moving average price of $4.77 and a 200-day moving average price of $5.44. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. The firm has a market cap of $1.51 billion, a price-to-earnings ratio of -5.27 and a beta of 0.54.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.07). The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business’s revenue was up 38.7% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.04) earnings per share. On average, analysts expect that agilon health, inc. will post -0.32 earnings per share for the current fiscal year.

Insider Activity

In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The stock was bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

A number of large investors have recently bought and sold shares of AGL. Capital International Investors raised its holdings in agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after acquiring an additional 9,263,296 shares during the last quarter. Capital World Investors increased its stake in agilon health by 7.4% in the fourth quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock valued at $692,992,000 after purchasing an additional 3,813,214 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in agilon health by 46.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock worth $127,256,000 after buying an additional 3,195,087 shares during the period. AQR Capital Management LLC boosted its stake in agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after buying an additional 1,316,990 shares during the last quarter. Finally, Wellington Management Group LLP grew its holdings in agilon health by 2.9% in the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock valued at $533,501,000 after buying an additional 1,191,253 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.